Inventor · Concord, MA, US

Eric Furfine

52Patents
18h-index
81Co-inventors
87Inventor score

Filing activity: Mar 28, 1996 → Oct 23, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US8092803B2 VEGF antagonist formulations for intravitreal administration Chemistry; Metallurgy 103 Active
US7608261B2 VEGF antagonist formulations suitable for intravitreal administration Chemistry; Metallurgy 87 Active
US8221765B2 Multivalent fibronectin based scaffold domain proteins Chemistry; Metallurgy 63 Active
US7807164B2 Lyophilized VEGF antagonist formulations for intravitreal administration Chemistry; Metallurgy 60 Active
US10464992B2 VEGF antagonist formulations suitable for intravitreal administration Chemistry; Metallurgy 59 Active
US9340594B2 VEGF antagonist formulations for intravitreal administration Chemistry; Metallurgy 56 Active
US8481046B2 VEGF antagonist formulations for intravitreal administration Chemistry; Metallurgy 55 Active
US9580489B2 VEGF antagonist formulations suitable for intravitreal administration Chemistry; Metallurgy 49 Active
US8802107B2 VEGF antagonist formulations for intravitreal administration Chemistry; Metallurgy 48 Active
US9914763B2 VEGF antagonist formulations suitable for intravitreal administration Chemistry; Metallurgy 41 Active
US8969289B2 Serum albumin binding molecules Chemistry; Metallurgy 40 Active
US10400025B2 VEGF antagonist formulations suitable for intravitreal administration Chemistry; Metallurgy 40 Active
US8728483B2 Multivalent fibronectin based scaffold domain proteins Chemistry; Metallurgy 36 Active
US6319946A Inhibitors of aspartyl protease Chemistry; Metallurgy 35 Expired
US6811780B2 Methods of using cytokine antagonists to treat HIV infection and AIDS Human Necessities 32 Expired
US7531172B2 Methods of treating diseases with a VEGF antagonist Human Necessities 28 Active
US9902762B2 Multivalent fibronectin based scaffold domain proteins Chemistry; Metallurgy 27 Active
US9540424B2 Serum albumin binding molecules Chemistry; Metallurgy 26 Active
US11084865B2 VEGF antagonist formulations suitable for intravitreal administration Chemistry; Metallurgy 13 Active
US11066458B2 VEGF antagonist formulations suitable for intravitreal administration Chemistry; Metallurgy 12 Active
US10221438B2 Serum albumin binding molecules Chemistry; Metallurgy 10 Active
US6559137B1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors Chemistry; Metallurgy 8 Expired
US8388963B2 Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof Human Necessities 7 Active
US6613743B2 Sulfonamide inhibitors of aspartyl protease Chemistry; Metallurgy 6 Expired
US9951130B2 IL-6 antagonists and uses thereof Chemistry; Metallurgy 4 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.